LMAT (LeMaitre Vascular) Cyclically Adjusted PS Ratio: (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMAT LeMaitre Vascular Inc LMAT
100 GF Score
Price $81.45
GF Value $95.26
Valuation Modestly Undervalued
View Full Analysis

What is LeMaitre Vascular Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


LeMaitre Vascular  (NAS:LMAT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LeMaitre Vascular Cyclically Adjusted PS Ratio Related Terms


LeMaitre Vascular Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for LeMaitre Vascular's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular Cyclically Adjusted PS Ratio Chart

LeMaitre Vascular Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.87 7.31 8.31 12.39 9.98

LeMaitre Vascular Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.58 10.92 9.98 12.96 11.10

LMAT vs PLSE, XRAY, ATRC: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Cyclically Adjusted PS Ratio falls into.


LMAT
100GF Score
LeMaitre Vascular Inc LMAT
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeMaitre Vascular Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LeMaitre Vascular's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, LeMaitre Vascular's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.869/333.9520*333.9520
=2.869

Current CPI (Jun. 2026) = 333.9520.

LeMaitre Vascular Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.206 241.428 1.668
201612 1.185 241.432 1.639
201703 1.225 243.801 1.678
201706 1.289 244.955 1.757
201709 1.232 246.819 1.667
201712 1.293 246.524 1.752
201803 1.288 249.554 1.724
201806 1.334 251.989 1.768
201809 1.191 252.439 1.576
201812 1.406 251.233 1.869
201903 1.410 254.202 1.852
201906 1.456 256.143 1.898
201909 1.428 256.759 1.857
201912 1.474 256.974 1.916
202003 1.495 258.115 1.934
202006 1.218 257.797 1.578
202009 1.779 260.280 2.283
202012 1.821 260.474 2.335
202103 1.721 264.877 2.170
202106 1.940 271.696 2.385
202109 1.749 274.310 2.129
202112 1.784 278.802 2.137
202203 1.790 287.504 2.079
202206 1.903 296.311 2.145
202209 1.757 296.808 1.977
202212 1.842 296.797 2.073
202303 2.113 301.836 2.338
202306 2.232 305.109 2.443
202309 2.109 307.789 2.288
202312 2.177 306.746 2.370
202403 2.369 312.332 2.533
202406 2.458 314.175 2.613
202409 2.401 315.301 2.543
202412 2.428 315.605 2.569
202503 2.615 319.799 2.731
202506 2.806 322.561 2.905
202509 2.503 324.800 2.574
202512 2.806 324.054 2.892
202603 2.890 330.213 2.923
202606 2.869 333.952 2.869

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is LeMaitre Vascular (LMAT) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued. The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.26. GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.

Key valuation signals for LMAT:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $95.26 vs. price of $81.45 (14.5% below fair value)
  • GF Score™: 100/100

No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LeMaitre Vascular Business Description

Other Exchanges LHU:Germany
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score

Get the complete analysis for LMAT

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.45
Price
$95.26
GF Value